IOL Chemicals and Pharmaceuticals has set up a new Unit-VII to manufacture Metformin with an installed capacity of 7,200 tpa. The Metformin is primarily used for the treatment of diabetes.
The company already has manufacturing facilities of Metformin (Unit-IV) with an existing installed capacity of 4,000 tpa.
With the installation of Unit-VII, the total manufacturing capacity of Metformin has now increased by about three folds at 11,200 tpa as compared to the existing capacity.
The manufacturing unit has been set up with capital expenditure (capex) of around Rs 28 crore, which has been funded fully through internal accruals only.
The manufacturing unit has been established at the existing plant site of the company at Barnala, Punjab.